A novel CAR T-cell therapy has benefitted patients with relapsed acute lymphoblastic leukemia, showing high response rates in ...
A new study provides important insights into how T-cells, a type of immune cell, become activated. Researchers employed a technique called Bayesian metamodeling, which combines data from different ...
A new chimeric antigen receptor T cell (CAR-T) therapy has delivered promising results in treating patients with an ...
SCG has revealed late-breaking data outcomes from the Phase I clinical trial of autologous hepatitis B virus (HBV)-specific T ...
One-third of HER2-positive (HER2+) tumors express the P95HER2 protein, which associates with an aggressive form of breast ...
A small trial used designer CAR T cells to reboot the immune systems of patients with three autoimmune diseases, but it's ...
One-third of HER2-positive (HER2+) tumors express the P95HER2 protein, which associates with an aggressive form of breast ...
Researchers report results of the first-in-human phase 1 clinical trials of a novel immunotherapy approach for solid tumors ...
cells can be genetically modified to express chimeric antigen receptors (CARs) to target cancer cells more effectively, an ...
T therapy targeting p95HER2 shows complete and durable tumor responses in HER2+ breast cancer preclinical models. Combining ...
Science X is a network of high quality websites with most complete and comprehensive daily coverage of the full sweep of science, technology, and medicine news ...